# Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

> **NCT01243541** · NA · TERMINATED · sponsor: **Northwestern University** · enrollment: 33 (actual)

## Conditions studied

- Chemotherapeutic Agent Toxicity
- Pain
- Peripheral Neuropathy
- Recurrent Breast Cancer
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer
- Therapy-related Toxicity

## Interventions

- **PROCEDURE:** cryotherapy
- **OTHER:** questionnaire administration
- **PROCEDURE:** quality-of-life assessment
- **PROCEDURE:** management of therapy complications
- **PROCEDURE:** assessment of therapy complications

## Key facts

- **NCT ID:** NCT01243541
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11-03
- **Primary completion:** 2014-04-04
- **Final completion:** 2014-04-04
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** PI decision due to low accrual and lack of funding
- **Last updated:** 2019-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243541, "Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01243541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*